We are live on
!
Find out more
Nautilus Biotechnolgy
NAUT
NAUT
68 hedge funds and large institutions have $114M invested in Nautilus Biotechnolgy in 2025 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 15 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
400% more call options, than puts
Call options by funds: $5K | Put options by funds: $1K
133% more capital invested
Capital invested by funds: $48.9M → $114M (+$65M)
57% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 7
20% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 15
0.4% more ownership
Funds ownership: 45.84% → 46.25% (+0.4%)
0% more funds holding
Funds holding: 68 → 68 (0)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
68
Holders Change
–
Holders Change %
0%
% of All Funds
0.83%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
11
Increased
18
Reduced
15
Closed
7
Calls
$5K
Puts
$1K
Net Calls
+$4K
Net Calls Change
+$4K
Top Buyers
| 1 |
ST
Sentinel Trust
Houston,
Texas
|
+$1.23M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$605K |
| 3 |
Goldman Sachs
New York
|
+$295K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$273K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$192K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$1.23M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$254K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$222K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$215K |
| 5 |
Squarepoint
New York
|
-$198K |
